Rigel Pharmaceuticals (RIGL) Treasury Shares (2021 - 2026)

Rigel Pharmaceuticals' Treasury Shares history runs 6 years deep, the most recent figure standing at $67200.0 for Q1 2026.

• On a quarterly basis, Treasury Shares fell 88.17% year-over-year to $67200.0 in Q1 2026; TTM through Mar 2026 was $67200.0, a 88.17% decrease from a year earlier, with the FY2025 full-year figure at $607621.0, up 56.89% from the prior year.
• Treasury Shares declined to $67200.0 in Q1 2026 per RIGL's latest filing, from $607621.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $4.1 million in Q1 2024 and bottomed at $67200.0 in Q1 2026.
• The 5-year median for Treasury Shares is $607621.0 (2025), against an average of $1.1 million.
• Across the five-year window, Treasury Shares jumped 387.8% in 2022 and plunged 88.17% in 2026, its largest moves.
• Year by year, Treasury Shares stood at $1.1 million in 2022, then tumbled by 83.15% to $185938.0 in 2023, then jumped by 108.29% to $387282.0 in 2024, then soared by 56.89% to $607621.0 in 2025, then plunged by 88.94% to $67200.0 in 2026.
• Per Business Quant, the three latest RIGL Treasury Shares figures stand at $67200.0 (Q1 2026), $607621.0 (Q4 2025), and $569106.0 (Q3 2025).